Kala Pharmaceuticals Adds 6% In Morning Trade

On:

Shares of Kala Pharmaceuticals, Inc. (KALA) are rising more than 6% Friday morning at $16.43.

The company today said Combangio, Inc., a unit of Kala, has been awarded a $15 million grant by the California Institute for Regenerative Medicine (CIRM) to support the company’s ongoing study of KPI-012 for the treatment of persistent corneal epithelial defect (PCED).

KALA has traded in the range of $3.54-$56.72 in the last 1 year.

Source: Read Full Article

Lates News:
  1. FuboTV Gains 9% In Pre-market On Increased Q3 Revenue Outlook
  2. Can Bitcoin Maintain the Latest Rally? Experts Express Mixed Reactions
  3. Rate Hikes And Recession Fears Dampen Market Sentiment
  4. Bitcoin (BTC) Market Cap Overtakes Berkshire Hathaway and Tesla – Now Among Top 10 Assets Globally
  5. $BTC: Legendary Investor Paul Tudor Jones Says He Has ‘Always’ Owned Some Bitcoin